Insiders · FGEN

FGEN insider transactions

FibroGen Inc (FGEN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for FGEN

• 181d
  Chief Financial Officer Delucia David covered exercise/tax liability with 52 shares, decreasing direct ownership by 1% to 4,489 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 181d
  CEO Wettig Thane covered exercise/tax liability with 259 shares, decreasing direct ownership by 1% to 24,680 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 203d
  CEO Wettig Thane bought $33,750 worth of shares (3,700 units at $9.12), increasing direct ownership by 17% to 24,939 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 272d
  Chief Financial Officer Delucia David covered exercise/tax liability with 104 shares, decreasing direct ownership by 2% to 4,541 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 272d
  CEO Wettig Thane covered exercise/tax liability with 494 shares, decreasing direct ownership by 2% to 21,239 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 341d
  Director Schoeneck James A bought $119,485 worth of shares (23,567 units at $5.07) (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 367d
  SEC Form 4 filed by Director Ho Maykin

  4 - FIBROGEN INC (0000921299) (Issuer)
• 367d
  SEC Form 4 filed by Director Edwards Jeffrey L

  4 - FIBROGEN INC (0000921299) (Issuer)
• 367d
  SEC Form 4 filed by Director Schoeneck James A

  4 - FIBROGEN INC (0000921299) (Issuer)
• 367d
  SEC Form 4 filed by Director Kauffman Michael

  4 - FIBROGEN INC (0000921299) (Issuer)
• 367d
  SEC Form 3 filed by new insider Kauffman Michael

  3 - FIBROGEN INC (0000921299) (Issuer)
• 441d
  CEO Wettig Thane bought $50,663 worth of shares (145,000 units at $0.35), increasing direct ownership by 36% to 543,329 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 442d
  Director Schoeneck James A bought $105,040 worth of shares (300,000 units at $0.35) (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 458d
  CEO Wettig Thane covered exercise/tax liability with 22,405 shares and was granted 781 shares, decreasing direct ownership by 5% to 398,329 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 458d
  SVP, CHINA OPERATIONS Chung Christine covered exercise/tax liability with 7,430 shares and was granted 781 shares, decreasing direct ownership by 2% to 294,903 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 458d
  Chief Financial Officer Delucia David covered exercise/tax liability with 2,325 shares, decreasing direct ownership by 2% to 116,137 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 514d
  SEC Form 4 filed by Chief Financial Officer Delucia David

  4 - FIBROGEN INC (0000921299) (Issuer)
• 514d
  SEC Form 4 filed by CEO Wettig Thane

  4 - FIBROGEN INC (0000921299) (Issuer)
• 537d
  New insider Delucia David claimed ownership of 118,462 shares (SEC Form 3)

  3 - FIBROGEN INC (0000921299) (Issuer)
• 546d
  CHIEF FINANCIAL OFFICER Graham Juan covered exercise/tax liability with 2,512 shares, decreasing direct ownership by 2% to 164,863 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 546d
  CEO Wettig Thane covered exercise/tax liability with 2,363 shares, decreasing direct ownership by 0.56% to 419,953 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 546d
  SVP, CHINA OPERATIONS Chung Christine covered exercise/tax liability with 2,792 shares, decreasing direct ownership by 0.92% to 301,552 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 637d
  CHIEF FINANCIAL OFFICER Graham Juan covered exercise/tax liability with 17,115 shares, decreasing direct ownership by 9% to 167,375 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 637d
  CEO Wettig Thane covered exercise/tax liability with 2,363 shares, decreasing direct ownership by 0.56% to 422,316 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 637d
  SVP, CHINA OPERATIONS Chung Christine covered exercise/tax liability with 17,395 shares, decreasing direct ownership by 5% to 304,344 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 672d
  CEO Wettig Thane covered exercise/tax liability with 20,840 shares, decreasing direct ownership by 5% to 424,679 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 713d
  CEO Wettig Thane covered exercise/tax liability with 782 shares, decreasing direct ownership by 0.18% to 445,519 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 725d
  Chief Medical Officer Adib Deyaa bought $25,884 worth of shares (22,123 units at $1.17), increasing direct ownership by 37% to 82,123 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 728d
  CHIEF FINANCIAL OFFICER Graham Juan covered exercise/tax liability with 18,979 shares, decreasing direct ownership by 9% to 184,490 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 731d
  Wettig Thane covered exercise/tax liability with 2,255 shares, decreasing direct ownership by 0.50% to 446,301 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 731d
  Chung Christine covered exercise/tax liability with 19,289 shares, decreasing direct ownership by 6% to 321,739 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 732d
  SEC Form 4 filed by Brennan Aoife

  4 - FIBROGEN INC (0000921299) (Issuer)
• 732d
  SEC Form 4 filed by Schoeneck James A

  4 - FIBROGEN INC (0000921299) (Issuer)
• 732d
  SEC Form 4 filed by Blaug Suzanne

  4 - FIBROGEN INC (0000921299) (Issuer)
• 732d
  SEC Form 4 filed by Cravatt Benjamin

  4 - FIBROGEN INC (0000921299) (Issuer)
• 732d
  SEC Form 4 filed by Ho Maykin

  4 - FIBROGEN INC (0000921299) (Issuer)
• 732d
  SEC Form 4 filed by Edwards Jeffrey L

  4 - FIBROGEN INC (0000921299) (Issuer)
• 732d
  SEC Form 4 filed by Lema Gerald

  4 - FIBROGEN INC (0000921299) (Issuer)
• 767d
  Wettig Thane covered exercise/tax liability with 20,840 shares, decreasing direct ownership by 4% to 448,556 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 775d
  New insider Adib Deyaa claimed ownership of 60,000 shares (SEC Form 3)

  3 - FIBROGEN INC (0000921299) (Issuer)
• 805d
  Wettig Thane covered exercise/tax liability with 782 shares, decreasing direct ownership by 0.17% to 469,396 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 819d
  Wettig Thane bought $95,470 worth of shares (50,000 units at $1.91), increasing direct ownership by 12% to 470,178 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 822d
  Graham Juan was granted 781 shares and covered exercise/tax liability with 21,930 shares, decreasing direct ownership by 9% to 203,469 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 822d
  Wettig Thane covered exercise/tax liability with 4,535 shares and was granted 781 shares, decreasing direct ownership by 0.89% to 420,178 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 822d
  Chung Christine covered exercise/tax liability with 23,590 shares and was granted 781 shares, decreasing direct ownership by 6% to 341,028 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 836d
  Wettig Thane was granted 166,000 shares, increasing direct ownership by 64% to 423,932 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 836d
  Chung Christine was granted 29,000 shares, increasing direct ownership by 9% to 363,837 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 836d
  Graham Juan was granted 52,000 shares, increasing direct ownership by 30% to 224,618 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 854d
  Wettig Thane covered exercise/tax liability with 23,490 shares, decreasing direct ownership by 8% to 257,932 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 895d
  Wettig Thane covered exercise/tax liability with 819 shares, decreasing direct ownership by 0.29% to 281,422 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 910d
  Graham Juan covered exercise/tax liability with 16,658 shares, decreasing direct ownership by 9% to 172,618 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 910d
  Chung Christine covered exercise/tax liability with 18,182 shares, decreasing direct ownership by 5% to 334,837 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 910d
  Wettig Thane covered exercise/tax liability with 1,680 shares, decreasing direct ownership by 0.59% to 282,241 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 948d
  Wettig Thane covered exercise/tax liability with 21,841 shares, decreasing direct ownership by 7% to 283,921 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 987d
  Wettig Thane covered exercise/tax liability with 819 shares, decreasing direct ownership by 0.27% to 305,762 units (SEC Form 4)

  4 - FIBROGEN INC (0000921299) (Issuer)
• 1004d
  SEC Form 4: Graham Juan covered exercise/tax liability with 1,807 shares, decreasing direct ownership by 0.95% to 189,276 units

  4 - FIBROGEN INC (0000921299) (Issuer)
• 1004d
  SEC Form 4: Wettig Thane covered exercise/tax liability with 1,680 shares, decreasing direct ownership by 0.54% to 306,581 units

  4 - FIBROGEN INC (0000921299) (Issuer)
• 1004d
  SEC Form 4: Eisner Mark covered exercise/tax liability with 1,860 shares, decreasing direct ownership by 1% to 159,917 units

  4 - FIBROGEN INC (0000921299) (Issuer)
• 1004d
  SEC Form 4: Chung Christine covered exercise/tax liability with 3,308 shares, decreasing direct ownership by 0.93% to 353,019 units

  4 - FIBROGEN INC (0000921299) (Issuer)
• 1006d
  SEC Form 4: Eisner Mark covered exercise/tax liability with 1,085 shares, decreasing direct ownership by 0.67% to 161,777 units

  4 - FIBROGEN INC (0000921299) (Issuer)